- Photoacoustic Imaging
- Optical Coherence Tomography (OCT)
- Hyperspectral Imaging
- Near Infrared Spectroscopy
Asia Pacific Optical Imaging Market size was valued at USD x billion in 2022 and is poised to grow at a CAGR of 12.2% from 2023-2029. Optical Imaging refers to the use of light as an imaging technique for medical applications. These optical techniques include optical microscopy, spectroscopy, endoscopy, scanning laser ophthalmoscopy, and optical coherence tomography. Optical imaging is an emerging technology with great potential for improving disease prevention, diagnosis and treatment. Furthermore, optical imaging has its application in the preclinical and clinical development of the pharmaceutical and biopharmaceutical products. The factors contributing to growth are Japan ageing population who are susceptible to the ophthalmological disorders and technological advancements in optical imaging. Furthermore, Japan company Nikon has entered into the medical devices market with the acquisition of retinal imaging firm Optos Plc. China Optical Imaging Market is expected to have lucrative growth opportunity owing to rise in investment of government and companies in R&D in the healthcare sector. Companies in China optic imaging market are adopting the strategies such as acquisitions and mergers to increase their product portfolio. Australia & New Zealand Optical Imaging Market is expected to have significant growth rate owing to the prevalence of breast cancer and skin diseases. According to Australian Institute of Health and Welfare, an estimated 17,730 new breast cancer cases were diagnosed in 2017 and 65,976 people are living with breast cancer at the end of 2012. This report studies Asia Pacific Optical Imaging market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
Asia Pacific region is projected to be a fastest growing market for the optical imaging owing to the factors such as developing healthcare infrastructure, companies investments in developing and marketing products into emerging countries such as India and China due to its large patient pool. In addition, growing prevalence of dermatological and ophthalmological diseases coupled with the increase in healthcare spending by government and public in Asia expected to positively impact the growth of Asia Pacific optical imaging market. However, high developmental and installation costs are expected to hinder the Asia Pacific optical imaging market during the forecast period.
The asia pacific optical imaging market growing at a CAGR of 12.2%
The report covers the countries market data: China, India, Japan, Australia & New Zealand
Bioptigen Inc. (U.S.), Carl Zeiss AG (Germany), SpectraScience Inc. (U.S.), Cytoviva Inc. (Aetos Technologies Inc.) (U.S.), Optical Imaging Ltd. (Israel), Michelson Diagnostics Ltd. (U.K.), PerkinElmer Inc. (U.S.), Nikon Corporation (Japan),